fbpx

YOUR GUIDE TO STAYING INFORMED IN THE MARKETS

Subscribe for FREE Email Updates & Access To EXCLUSIVE Research!

9 Sectors Join Market’s Party Thursday – VP Watchlist Biotech Stocks Rise $ATOS $FATE $INMB $INM

By John F. Heerdink, Jr.
9 Sectors Join Market's Party Thursday
“Modern medical advances have helped millions of people live longer, healthier lives. We owe these improvements to decades of investment in medical research.” – Ike Skelton, American Politician, Born: December 20, 1931


Happy Thursday!

I hope you succeeded in making your health a priority today, while continuing to make a fortune in the markets. Growing your investments overall today was a bit easier as we had one of those broadly positive swings where all indices rose & the S&P 500 closed at 4,429.10 (+.60%) & the Nasdaq closed at 14,895.12 (+78%), both record highs. In addition, the big boys on Dow 30 closed at 35,064.25 (+.78%) & the smalls on the Russell 200o bounced up nicely closing at 2,236.01 (+1.81%). The microchips jumped strongly back in the game too as the iShares Micro-Cap ETF (IWC) closed at $144.75, (+2.09). Completely opposite to yesterday,  9 of the 11 S&P 500 sectors closed in the green led by the energy sector moving up 1.3% as oil prices rose to $69.09/bbl, +1.4%, the financials moving up 1.2%, & the utilities adding 1.1%, while the health care sector down .4% and the materials sector down  -.1% failed to join the party. 

The macroeconomic schedule delivered a couple of reports. The Initial jobless claims report for the week ending July 31 confirmed a drop by 14k to 385k & the continuing claims report for the week ending July 24 confirmed a drop by 366k to 2.930M, which is the lowest level since March 14, 2020. The trade deficit report confirmed a widening to $75.7B in June. Tomorrow’s schedule will bring the Employment Situation Report for July, the Consumer Credit report for June, & the Wholesale Inventories report for June. 

As part of a “stress capital buffer” regime established by the Fed, they announced how much each of the 34 large banks that underwent the most recent stress test will be required to hold on their books as capital cushions as of Oct.1, 2021.

The yield curve moved higher as the close the 10-yr treasury yield closed up 4 basis points at 1.22% & the 2-yr yield rose 3 basis points to close at .20%. The U.S. Dollar Index closed flat at 92.27. Gold prices rose $1 to close at $1,813 and silver closed at $25.42, +$.17.

BIOTECH BOUNCES

The SPDR S&P Biotech ETF (XBI) closed at $129.54, +3.8%, the iShares Nasdaq Biotechnology ETF (IBB) closed at $174.85, +1.57% & the NYSE ARCA Biotech Index (^BTK) closed at 6,002.61, +1.2%.

Shares of VP Watchlist firm, Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, closed at $3.33, +5.71% on 8.79M shares of trading volume after reaching $3.41 in intraday trading. 

Shares of VP Watchlist firm, Fate Therapeutics (FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, closed at $95.54/share, +11.44%. The 52-wk high is $121.16. 

Shares of VP Watchlist stock, INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease including Alzheimer’s disease, closed at $14.95, +5.8%. 

InMed Pharmaceuticals, Inc. (NASDAQ: INM) is leading clinical-stage pharmaceutical company developing cannabinoid-based drug candidates for high unmet medical needs and IntegraSyn, a proprietary and cost effective manufacturing approach for synthesized rare cannabinoids. Shares of InMed closed trading at $2.45, +7.93.

TECH

Massively weighted Apple (AAPL) beat analyst estimates last week with revenue increasing 36% Y/Y to $81.4B while iPhone revenue jumped ~+50% in Q2. Shares of Apple closed at $147.06, +.07% today.

Tesla (TSLA) ticked higher again today to close at $710.63, +.52%.

Shares of chip maker NVIDIA (NVDA) keeps on driving higher and closed at $206.37, +1.78% today after their recent 4-1 stock split as the chip shortage wars wage on. NVIDIA will host a conference call on Wednesday, August 18, at 2 p.m. PT (5 p.m. ET) to discuss its financial results for the second quarter of fiscal year 2022, which ended August 1, 2021. The call will be webcast live (in listen-only mode) on investor.nvidia.com. The company’s prepared remarks will be followed by a question and answer session, which will be limited to questions from financial analysts and institutional investors. Ahead of the call, NVIDIA will provide written commentary on its second-quarter results from its CFO. This material will be posted to investor.nvidia.com immediately after the company’s results are publicly announced at approximately 1:20 p.m. PT.

Microsoft (MSFT) closed at $289.52, +1.05%.

Amazon.com (AMZN) closed at 3,375.99, +.63%. Amazon today announced plans to open a fulfillment center in Port St. Lucie, FL that they believe will be launched in 2022 creating 500 new, full-time jobs.

MEMES 

AMC Entertainment (AMC) bounces to close at $33.51, +12.3%.

GameStop (GME) also closed at $153.44, +4.52%.

Virgin Galactic Holdings (SPCE) closed at $31.53, +2.44%. 

Robinhood Markets, Inc., went public last Thursday under the ticker ‘HOOD’ at a price of $38/share, but then dropped to a low of $33.25. They then proceeded to hit a high $85/share prior to announcing today that they are now selling up to 97.9 million Class A shares owned by shareholders. The stock closed at $50.97, -27.59%. 


VP WATCHLIST HIGHLIGHTS

Our complete VP Watchlist is a list that we believe deserves consideration for short term and long term portfolio adds that include Apple, Tesla, Disney & 8 other names currently. The dedicated pages for each of these companies will enable you to stay informed and learn more about these companies daily. Please review few of the updates on a few of the VP Watchlist companies below:


  • Shares of VP Watchlist stock, INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease including Alzheimer’s disease, closed at $14.95, +5.8%. 
    • On Wednesday, Aug. 4th, INmune Bio, Inc. reported its financial results for the second quarter ended June 30, 2021 and provided a business update. Raymond J Tesi, M.D., CEO/CMO of INmuneBio (INMB) stated, “We continue our planning and setup for a Phase 2 clinical trial of our lead candidate, XPRO™ (Xpro1595™), in patients with mild Alzheimer’s disease, which we plan to initiate by year-end. We have already demonstrated that XPRO™ can reduce neuroinflammation and decreases biomarkers of neurodegeneration and improve synaptic function. If successful in Phase 2, we believe XPRO™ has the potential to be among the most significant advancements in the treatment of Alzheimer’s Disease (AD) and other neurodegenerative diseases in many years. At the Alzheimer’s Association International Conference last week, we introduced a new biomarker – Apparent Fiber Density (AFD), a measure of axonal integrity measured by MRI. XPRO™ increases AFD in patients receiving 1mg/kg/week. We believe the novel non-invasive white matter analytics of white matter free water and apparent fiber density will be very useful in the development of XPRO™ in AD, Treatment Resistant Depression (TRD) and the many other CNS indications we hope to attack in the future. Last month, we treated the first patient in the first Phase 1 clinical trial of our NK cell priming platform, INKmune, in high-risk myelodysplastic syndrome (MDS). We are calling INKmune a pseudokine because, in vitro, it converts the resting NK cells into memory-like NK cells that can kill cancer cells as well or better than NK cells treated cytokines such as IL-12, IL-15 and IL-18 alone or in combination.”
    • On July 26th, INmune Bio announced the design of its upcoming Phase 2 clinical trial of XProTM in patients diagnosed with mild Alzheimer’s disease (AD) at AAIC. The announcement was accompanied by the release of additional biomarker data from the Phase 1b AD trial that shows improvement in white matter (myelinated axons) that degenerate in AD patients. READ MORE. 
  •  
  •  
 

  • Fate Therapeutics (FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for patients with cancer, closed at $95.54/share, +11.44%. The 52-wk high is $121.16. 
    • Today, August 4th, Fate reported business highlights and financial results for the second quarter ended June 30, 2021. Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics stated, “We are very pleased with the early clinical safety and activity we have observed with our off-the-shelf, iPSC-derived NK cell programs in relapsed / refractory lymphoma and acute myeloid leukemia, where interim Phase 1 data indicate FT516 and FT538 are well tolerated and can deliver complete responses for patients. We look forward to sharing additional clinical data from our FT516 and FT596 programs in B-cell lymphoma at our upcoming investor event. Additionally, treatment of the first patient with FT819, the first-ever iPSC-derived T-cell therapy to undergo clinical investigation, is a landmark achievement and further demonstrates the Company’s leadership in off-the-shelf, iPSC-derived cell therapy and the versatility of its proprietary iPSC Product Platform.”
    • On Aug. 2 Fate announced that the first patient has been treated with FT819, an off-the-shelf chimeric antigen receptor (CAR) T-cell therapy targeting CD19+ malignancies. FT819 is the first-ever CAR T-cell therapy derived from a clonal master induced pluripotent stem cell (iPSC) line, a renewable cell source that enables mass production of high quality, allogeneic CAR T cells with greater product consistency, off-the-shelf availability, and broader patient accessibility. FT819 is engineered with several first-of-kind features designed to improve the safety and efficacy of CAR T-cell therapy.


  • INVO Bioscience (NASDAQ: INVO) is a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of INVOcell®, the world’s only in vivo Intravaginal Culture System. Shares of INVO closed at $4.32%.
    • INVO will report financial results for its second quarter 2021, ended June 30, 2021, after the market close on Monday, August 16, 2021. The Company has scheduled a conference call that same day, Monday, August 16, 2021, at 4:30 pm ET, to review the results. nterested parties can access the conference call by dialing 833-756-0861 or 412-317-5751. A a live webcast, which is available in the Investor Relations section of the Company’s website at https://www.invobioscience.com/investors/ or https://www.webcaster4.com/Webcast/Page/2162/42110.
    • On Aug.2, INVO announced the Company’s first Joint Venture INVO Center practice in the United States, based in Birmingham, Alabama, will officially open on August 9, 2021. Dr. Hammond commented, “With the opening of the country’s first INVOcell medical practice, we are advancing a core mission towards improving access to advanced fertility services for the many patients who would otherwise never have the opportunity. To date, we have already received numerous advanced inquiries via word of mouth and have dozens of patients scheduled for initial patient consultations who are eager to proceed with treatment. As we officially open the center next week, we expect to accelerate our marketing programs with the help of the INVO marketing team to enhance overall patient awareness around Innovative Fertility Specialists, An INVO Center.”


  • Shares of VP Watchlist firm, Seattle-based Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, closed at $3.33, +5.71% on 8.79M shares of trading volume after reaching $3.41 in intraday trading. 
    • On July 7th, Atossa Therapeutics, Inc. (Nasdaq: ATOS), announced that it has received regulatory approval from HREC (Human Research Ethics Committee) to open a clinical study of AT-H201 in Australia. The nebulized formulation, AT-H201, is being developed as an inhalation therapy for moderately to severely-ill hospitalized COVID-19 patients and for “long-haul” patients with post-infection pulmonary disease. AT-H201 is a proprietary combination of two drugs previously approved by the FDA to treat other diseases and by other administration routes. AT-H201 is intended to be inhaled via a nebulizer to improve compromised lung function for moderate to severely ill, hospitalized COVID-19 patients and for “long-haul” patients with post-infection pulmonary disease. In May 2020, we completed in vitro testing of AT-H201 which showed that the components of AT-H201 inhibit SARS-CoV-2 infectivity of VERO cells, which is a standard cell type being used to study infectivity of the coronavirus. The AT-H201 components were found to be at least four times more potent than Remdesivir and at least 20 times more potent than Hydroxychloroquine. Potency was measured by microscopic examination of the cytopathic effect caused by SARS-CoV-2 in VERO cells.


  • InMed Pharmaceuticals, Inc. (NASDAQ: INM) is leading clinical-stage pharmaceutical company developing cannabinoid-based drug candidates for high unmet medical needs and IntegraSyn, a proprietary and cost effective manufacturing approach for synthesized rare cannabinoids. Shares of InMed closed trading at $2.45, +7.93. The 52-wk range is $2.20 – $8.94. On July 9th, Roth Capital Partners analyst Scott Henry, CFA issued an update report with a BUY Rating titled, “INM: Favorable Take on BayMedica LOI” that includes a $11.50 12-Month Price target.
    • On July 2nd, InMed announced that it had closed the previously announced private placement and after deducting the placement agent fees and estimated offering expenses payable by the Company, the Company received net proceeds of approximately US$11 million. H.C. Wainwright & Co. acted as the exclusive placement agent for the private placement. Under the terms of the private placement, an aggregate of 4,036,327 common shares (or common share equivalents in lieu thereof) and warrants to purchase up to an aggregate of 4,036,327 common shares were purchased, at an effective purchase price of US$2.973 per common share (or common stock equivalent in lieu thereof) and associated warrant. The warrants have an exercise price of US$2.848 per share, are exercisable immediately and have a term of five years. InMed intends to use the net proceeds from the offering to continue pipeline development, advance business development activities and for general working capital purposes.
    • On June 29th, INM announced that it has entered into a non-binding letter of intent (the “LOI”) to acquire BayMedica Inc. (“BayMedica”), a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids. BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable, and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is currently planning additional rare cannabinoid launches for the coming year. In addition to their manufacturing and commercial activities in the health and wellness arena, BayMedica is researching cannabinoid analogs as potential drug candidates for pharmaceutical purposes. Those BayMedica proprietary compounds are based upon the structures of naturally-occurring cannabinoids and are designed to either augment the potential therapeutic effect against specific diseases or enhance product safety, or both.

Economic Reports

  • On Monday, the macroeconomic schedule delivered the July ISM Manufacturing Index report came in slightly lower at 59.5%, but still in the expansion territory. The total construction spending report confirmed a .1% month/month higher move in June. The total private construction report moved up .4% month/month. Total public construction spending dropped 1.2%. The final IHS Market Manufacturing PMI for June was confirmed at 63.4.
  • On Tuesday, the Factory Orders report for June confirmed a rise of 1.5%.
  • On Wednesday, the ISM Non-Manufacturing Index report for July showed a rise to 64.1% again confirming expansion again well above the Mendoza line. However, the ADP Employment Change report confirmed an estimated 330k jobs were added to private-sector payrolls in July, unfortunately substantially less than the expected 650k.  The final reading for the July IHS Markit Services PMI came in slightly higher at 59.9 & the weekly MBA Mortgage Applications Index report confirmed a drop by 1.7%.
  • On Thursday, the Initial jobless claims report for the week ending July 31 confirmed a drop by 14k to 385k & the continuing claims report for the week ending July 24 confirmed a drop by 366k to 2.930M, which is the lowest level since March 14, 2020. The trade deficit report confirmed a widening to $75.7B in June.

Investing & Inspiration

  1. “Modern medical advances have helped millions of people live longer, healthier lives. We owe these improvements to decades of investment in medical research.” – Ike Skelton
  2. “In every investment, before I get involved or invest, I always see what the mindset of the founder, the CEO, is.” – Zaza Pachulia
  3. “An investment said to have an 80% chance of success sounds far more attractive than one with a 20% chance of failure. The mind can’t easily recognize that they are the same.” – Daniel Kahneman
  4. “The return on investment in global health is tremendous, and the biggest bang for the buck comes from vaccines. Vaccines are among the most successful and cost-effective health investments in history.” – Seth Berkley
  5. “Few things in the world are more powerful than a positive push. A smile. A world of optimism and hope. A ‘you can do it’ when things are tough.” – Richard M. DeVos
  6. “To be yourself in a world that is constantly trying to make you something else is the greatest accomplishment.” – Ralph Waldo Emerson
  7. “We all have dreams. But in order to make dreams come into reality, it takes an awful lot of determination, dedication, self-discipline, and effort.”  – Jesse Owens
  8. “The pessimist complains about the wind; the optimist expects it to change; the realist adjusts the sails.” – William Arthur Ward- American Writer, Born 1921
  9. “Once you replace negative thoughts with positive ones, you’ll start having positive results.” – Willie Nelson
  10. “The secret of your future is hidden in your daily routine.” – Mike Murdock
  11.  “If somebody puts you down or criticizes you, just keep on believing in yourself and turn it into something positive.” – Leah LaBelle
  12. “Opportunity is missed by most people because it is dressed in overalls and looks like work”. -Thomas A. Edison
  13. “Education is not only a ladder of opportunity, but it is also an investment in our future.” – Ed Markey
  14. “Human behavior flows from three main sources: desire, emotion, and knowledge.” – Plato

  15. “We are what our thoughts have made us; so take care about what you think. Words are secondary. Thoughts live; they travel far.” – Swami Vivekananda
  16. “Success is not final, failure is not fatal: it is the courage to continue that counts.” – Winston Churchill
  17. “If you don’t know where you are going, any road will get you there.” – Lewis Carroll

  18. “Don’t worry about being a star, worry about doing good work, and all that will come to you.” – Ice Cube

  19. “It is not in the stars to hold our destiny but in ourselves.” – William Shakespeare

  20. Prediction is very difficult, especially if it’s about the future.” – Niels Bohr (Danish Physicist)
  21. “It is indeed true that the stock market can forecast the business cycle.” -Paul Samuelson

  22. “The wisest rule in investment is: when others are selling, buy. When others are buying, sell. Usually, of course, we do the opposite. When everyone else is buying, we assume they know something we don’t, so we buy. Then people start selling, panic sets in, and we sell too.” – Jonathan Sacks

  23. “What lies behind you and what lies in front of you, pales in comparison to what lies inside of you.” – Ralph Waldo Emerson
  24. “Each new generation born is in effect an invasion of civilization by little barbarians, who must be civilized before it is too late.” – Thomas Sowell
  25. “Life is 10% what happens to you and 90% how you react to it.” – Charles R. Swindoll
  26. “The truth is you don’t know what is going to happen tomorrow. Life is a crazy ride, and nothing is guaranteed.” – Eminem
  27. “View health as an investment, not an expense.” – John Quelch

  28. “Opportunity does not knock, it presents itself when you beat down the door.” – Kyle Chandler

  29. “If you don’t know where you are going, any road will get you there.” – Lewis Carroll
  30. “Once you replace negative thoughts with positive ones, you’ll start having positive results.” – Willie Nelson
  31. “That which does not kill us makes us stronger.” – Friedrich Nietzsche
  32. “Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” – Marie Curie
  33. “A problem is a chance for you to do your best.”–  Duke Ellington
  34. “The best way to predict the future is to create it.” -Peter Drucker
  35. “I’m involved in the stock market, which is fun and, sometimes, very painful.” – Regis Philbin
  36. “Who owns the future? This is the question at the heart of every stock market.” – John Landgraf
  37. “One of the funny things about the stock market is that every time one person buys, another sells, and both think they are astute.” – William Feather
  38. While I’m sure some millennials are concerned with the ethical issues involved in mining for diamonds, the main reason they steer clear of the gems is because, well, they’re a dumb investment.” – Ana Kasparian
  39. “The wisest rule in investment is: when others are selling, buy. When others are buying, sell. Usually, of course, we do the opposite. When everyone else is buying, we assume they know something we don’t, so we buy. Then people start selling, panic sets in, and we sell too.” – Jonathan Sack
  40. “We must shift our thinking away from short-term gain toward long-term investment and sustainability, and always have the next generations in mind with every decision we make.” –  Deb Haaland
  41. “The only way to have a friend is to be one.” –  Ralph Waldo Emerson
  42. “If you believe in yourself and have dedication and pride – and never quit, you’ll be a winner. The price of victory is high but so are the rewards.” – Bear Bryant
  43. “Investing in women’s lives is an investment in sustainable development, in human rights, in future generations – and consequently in our own long-term national interests.” -Liya Kebede

  44. “Success is not final, failure is not fatal: it is the courage to continue that counts.”– Winston Churchill
  45. “Our greatest glory is not in never falling, but in rising every time we fall.” – Confucius

  46. “Give me a lever long enough and a fulcrum on which to place it, and I shall move the world.” – Archimedes
  47. “Who controls the past controls the future. Who controls the present controls the past.” – George Orwell
  48. “If you get up in the morning and think the future is going to be better, it is a bright day. Otherwise, it’s not.” – Elon Musk
  49. “The pessimist complains about the wind; the optimist expects it to change; the realist adjusts the sails.” – William Arthur Ward
  50. “Start where you are. Use what you have. Do what you can.” – Arthur Ashe
  51. “Netflix, Amazon, iTunes – whatever platforms emerge – we are looking at as having the same potential that home video had for the movie business. Which means there are entirely new opportunities to monetize our capital investment in content and do so in ways that work for distributors, for consumers and for creators.” – Bob Iger
  52. “When you have no one to answer to, vendetta as investment strategy is as legitimate as anything.” – Carl Icahn

  53. “No other investment yields as great a return as the investment in education. An educated workforce is the foundation of every community and the future of every economy.” – Brad Henry
  54. “In my view, the biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital. Not only is the mere drop in stock prices not risk, but it is an opportunity. Where else do you look for cheap stocks?” – Li Lu
  55. “Modern medical advances have helped millions of people live longer, healthier lives.

  56. We owe these improvements to decades of investment in medical research.”– Ike Skelton

  57. “Stock market goes up or down, and you can’t adjust your portfolio based on the whims of the market, so you have to have a strategy in a position and stay true to that strategy and not pay attention to noise that could surround any particular investment.” – John Paulson

  58. “Your mindset matters. It affects everything – from the business and investment decisions you make, to the way you raise your children, to your stress levels and overall well-being.” – Peter Diamandis
  59. “Inflation destroys savings, impedes planning, and discourages investment. That means less productivity and a lower standard of living.” – Kevin Brady
  60. “Bitcoin, in the short or even long term, may turn out be a good investment in the same way that anything that is rare can be considered valuable. Like baseball cards. Or a Picasso.” – Andrew Ross Sorkin
  61. “I think you have to learn that there’s a company behind every stock and there’s only one real reason why stocks go up. Companies go from doing poorly to doing well or small companies grow to large companies.” – Peter Lynch
  62. “Historically, there has been a bull market in the commodities every 20 or 30 years.” – Jim Rogers
  63. “The markets generally are unpredictable, so that one has to have different scenarios. The idea that you can actually predict what’s going to happen contradicts my way of looking at the market.” – George Soros
  64. “Stop trying to predict the direction of the stock market, the economy or the elections.” – Warren Buffett
  65. “An important key to investing is to remember that stocks are not lottery tickets.” – Peter Lynch
  66. “Learn everyday, but especially from the experiences of others. It’s cheaper!” – John Bogle
  67. “When purchasing depressed stock in troubled companies, seek out the ones with the superior financial positions and avoid the ones with loads of bank debt.” – Peter Lynch
  68. “No stock price is too low for bears or too high for bulls.” – John F. Heerdink, Jr.
  69. “Investment is most successful when it is most businesslike.” – Ben Graham

  70. “Value stocks are about as exciting as watching grass grow, but have you ever noticed just how much your grass grows in a week?” – Christopher Browne

  71. “Even the intelligent investor is likely to need considerable willpower to keep from following the crowd.” – Benjamin Graham
  72. “Individual who cannot master their emotions are ill-suited to profit from the investment process.” – Benjamin Graham
  73. “I made my first investment at age eleven. I was wasting my life until then.” – Warren Buffet
  74. “I don’t look to jump over seven-foot bars; I look around for one-foot bars that I can step over.” — Warren Buffett
  75. “There are only three measurements that tell you nearly everything you need to know about your organization’s overall performance: employee engagement, customer satisfaction, and cash flow. It goes without saying that no company, small or large, can win over the long run without energized employees who believe in the mission and understand how to achieve it.” – Jack Welch, former CEO of GE
  76. “Opportunities come infrequently. When it rains gold, put out the bucket, not the thimble” ― Warren Buffett
  77. “If you buy things you do not need, soon you will have to sell things you need.” – Warren Buffet
  78. “How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case.” — Robert G. Allen
  79. “It’s far better to buy a wonderful company at a fair price, than a fair company at a wonderful price.” – Warren Buffett
  80. “A market downturn doesn’t bother us. It is an opportunity to increase our ownership of great companies with great management at good prices.” — Warren Buffett
  81. “Every once in a while, the market does something so stupid it takes your breath away.” — Jim Cramer
  82. “The person who starts simply with the idea of getting rich won’t succeed; you must have a larger ambition.” — John D. Rockefeller
  83. “Know what you own, and know why you own it.” – Peter Lynch
  84. “Although it’s easy to forget sometimes, a share is not a lottery ticket… it’s part ownership of a business.” – Peter Lynch
  85. “Wise spending is part of wise investing. And it’s never too late to start.” – Rhonda Katz
  86. “Invest for the long haul. Don’t get too greedy and don’t get too scared.” – Shelby M.C. Davis

  87. “Fear incites human action far more urgently than does the impressive weight of historical evidence.”
    -Jeremy Siegel
  88. “With a good perspective on history, we can have a better understanding of the past and present, and thus a clear vision of the future.” — Carlos Slim Helu
  89. “If we like a business, we’re going to buy as much of it as we can and keep it as long as we can. And when we change our mind, we don’t take half measures.” – Warren Buffett
  90. “The most contrarian thing of all is not to oppose the crowd but to think for yourself.” — Peter Thiel

  91. “Never depend on a single income, make an investment to create a second source.” Warren Buffet

  92. Games are won by players who focus on the playing field –- not by those whose eyes are glued to the scoreboard.”
    ― Warren Buffett
  93. “The key to making money in stocks is not to get scared out of them.” – Peter Lynch
  94. “Courage taught me no matter how bad a crisis gets … any sound investment will eventually pay off.” — Carlos Slim Helu
  95. “Investing puts money to work. The only reason to save money is to invest it.” – Grant Cardone
  96. “As time goes on, I get more and more convinced that the right method of investment is to put fairly large sums into enterprises which one thinks one knows something about and in the management of which one thoroughly believes.” — John Maynard Keynes
  97. “Given a 10% chance of a 100 times payoff, you should take that bet every time.” — Jeff Bezos
  98. “Money is always eager and ready to work for anyone who is ready to employ it.” ― Idowu Koyenikan
  99. The secret to investing is to figure out the value of something – and then pay a lot less.” – Joel Greenblatt
  100. “We don’t have an analytical advantage, we just look in the right place.” – Seth Klarman
  101. “Men, it has been well said, think in herds. It will be seen that they go mad in herds, while they only recover their senses slowly, and one by one.” – Charles Mackay
  102. “It’s not whether you’re right or wrong that’s important, but how much money you make when you’re right and how much you lose when you’re wrong.” – George Soros
  103. “No Price is too low for a bear or too high for a bull.” — Anonymous
  104. “Investment is an asset or item that is purchased with the hope that it will generate income or appreciate in the future.” Anonymous
  105. “Behind every stock is a company. Find out what it’s doing.” — Peter Lynch
  106. “Wise spending is part of wise investing. And it’s never too late to start.” –Rhonda Katz
  107. “It amazes me how people are often more willing to act based on little or no data than to use data that is a challenge to assemble.” ― Robert Shiller
  108. “A bull market is like sex. It feels best just before it ends.” — Barton Biggs
  109. “The investor’s chief problem — even his worst enemy — is likely to be himself.” — Benjamin Graham
  110. “No profession requires more hard work, intelligence, patience, and mental discipline than successful speculation.” – Robert Rhea
  111. “Money is like a sixth sense – and you can’t make use of the other five without it.” – William Somerset Maugham
  112. “Compound interest is the eighth wonder of the world. He who understands it, earns it. He who doesn’t, pays it.” — Albert Einstein
  113. “Never count on making a good sale. Have the purchase price be so attractive that even a mediocre sale gives good results” — Warren Buffett
  114. “The stock market is a device for transferring money from the impatient to the patient.” – Warren Buffett
  115. “Thousands of experts study overbought indicators, head-and-shoulder patterns, put-call ratios, the Fed’s policy on money supply…and they can’t predict markets with any useful consistency, any more than the gizzard squeezers could tell the Roman emperors when the Huns would attack.” – Peter Lynch
  116. “Investing puts money to work. The only reason to save money is to invest it.” – Grant Cardone
  117. “You cannot save time for your future use however you can invest time for your future.” – John F. Heerdink, Jr. 
  118. “Know what you own, and know why you own it.” – Peter Lynch
  119. “Liquidity is only there when you don’t need it.” -Old Proverb
  120. “If you want to be a millionaire, start with a billion dollars and launch a new airline.” – Richard Branson
  121. “Fear incites human action far more urgently than does the impressive weight of historical evidence.” – Jeremy Siegel
  122. “In investing, what is comfortable is rarely profitable.” – Robert Arnott
  123. “Spend each day trying to be a little wiser than you were when you woke up.” – Charlie Munger
  124. “The entrance strategy is actually more important than the exit strategy.” – Edward Lampert
  125. “The rivers don’t drink their own water; Trees don’t eat their own fruits. The sun does not shine for itself, And flowers do not spread their fragrance For themselves. Living for others is a rule of nature” – Pope Francis
  126. “It is impossible to produce superior performance unless you do something different from the majority.” – John Templeton
  127. “An investment in knowledge pays the best interest.” – Benjamin Franklin.
  128. I believe the returns on investment in the poor are just as exciting as successes achieved in the business arena, and they are even more meaningful!” -Bill Gates
  129. “Every portfolio benefits from bonds; they provide a cushion when the stock market hits a rough patch. But avoiding stocks completely could mean your investment won’t grow any faster than the rate of inflation.” – Suze Orman
  130. “The tax on capital gains directly affects investment decisions, the mobility, and flow of risk capital… the ease or difficulty experienced by new ventures in obtaining capital, and thereby the strength and potential for growth in the economy.” – John F. Kennedy
  131. “If all the economists were laid end to end, they’d never reach a conclusion. -George Bernard Shaw
  132. “There are old traders and there are bold traders, but there are very few old, bold traders.”-Ed Seykota
  133. “Let this scenario play out on its own, in its own fashion. As you watch it unfold, you will soon be grateful that you choose the peaceful path. Remember — those who live by the sword, die by the sword.”
  134. “As long as you enjoy investing, you’ll be willing to do the homework and stay in the game.” -Jim Cramer
  135. “I rarely think the market is right. I believe non-dividend stocks aren’t much more than baseball cards. They are worth what you can convince someone to pay for it.” -Mark Cuban
  136. Michael Marcus taught me one other thing that is absolutely critical: You have to be willing to make mistakes regularly; there is nothing wrong with it. Michael taught me about making your best judgment, being wrong, making your next best judgment, being wrong, making your third best judgment, and then doubling your money.” -Bruce Kovner
  137. “The policy of being too cautious is the greatest risk of all.” -Jawaharlal Nehru
  138. “The only true test of whether a stock is “cheap” or “high” is not its current price in relation to some former price, no matter how accustomed we may have become to that former price, but whether the company’s fundamentals are significantly more or less favorable than the current financial-community appraisal of that stock.” -Philip Fisher
  139. “I learned to avoid trying to catch up or double up to recoup losses. I also learned that a certain amount of loss will affect your judgment, so you have to put some time between that loss and the next trade.” -Richard Dennis
  140. “The four most dangerous words in investing are: ‘this time it’s different.” -Sir John Templeton
  141. “Money doesn’t make you happy. I now have $50 million but I was just as happy when I had $48 million.” -Arnold Schwarzenegger

Videos

Please consider viewing these interesting videos: